EADO 2026: Microbiome Biomarkers May Shape Immunotherapy in Melanoma

Brigitte Dréno, MD, Professor Emerita of Dermatology, Nantes University Hospital, Nantes, France, discussed the emerging role of the microbiome as a predictive biomarker for immunotherapy in melanoma at the EADO 2026 Congress. She explained how microbial composition may influence antitumour immunity and treatment response, while highlighting the challenges that remain before microbiome-guided patient selection can be implemented in clinical practice.